• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舌下含服硝苯地平对肥厚型心肌病患者血流动力学及收缩和舒张功能的影响。

Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.

作者信息

Betocchi S, Cannon R O, Watson R M, Bonow R O, Ostrow H G, Epstein S E, Rosing D R

出版信息

Circulation. 1985 Nov;72(5):1001-7. doi: 10.1161/01.cir.72.5.1001.

DOI:10.1161/01.cir.72.5.1001
PMID:4042288
Abstract

The hemodynamic effects of sublingual nifedipine were examined in 36 patients with hypertrophic cardiomyopathy. Twenty-one patients were initially given 20 mg and 15 patients were given 10 mg of the drug; 30 min after this first dose 26 patients received 10 mg and one patient 20 mg as a second dose. Hemodynamic findings in patients who received different doses of the drug were similar. Peak effects included an increase in heart rate from 79 +/- 12 to 91 +/- 14 (mean +/- 1 SD) beats/min (p less than .01), and a decrease in mean blood pressure from 89 +/- 12 to 77 +/- 10 mm Hg (p less than .01). Cardiac index increased after nifedipine (2.8 +/- 0.6 to 3.3 +/- 0.8 liters/min/m2; p less than .01); stroke volume index, however, did not change (36 +/- 7 to 36 +/- 8 ml/beat/m2; NS). Peripheral vascular resistance index fell significantly from 822 +/- 261 to 610 +/- 197 dynes X sec X cm-5 (p less than .01). Overall, left ventricular outflow tract gradient (LVOTG) did not change in patients with significant (greater than or equal to 30 mm Hg) basal LVOTG (75 +/- 22 to 83 +/- 22 mm Hg; NS), but it increased significantly in those six patients in whom peripheral vascular resistance fell by 25% or more (73 +/- 28 to 99 +/- 22 mm Hg; p less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对36例肥厚型心肌病患者进行了舌下含服硝苯地平的血流动力学效应研究。21例患者初始给予20mg药物,15例患者给予10mg药物;首剂给药30分钟后,26例患者接受10mg药物,1例患者接受20mg药物作为第二剂。接受不同剂量药物的患者血流动力学结果相似。峰值效应包括心率从79±12次/分钟增加到91±14次/分钟(平均值±1标准差)(p<0.01),平均血压从89±12mmHg降至77±10mmHg(p<0.01)。硝苯地平治疗后心脏指数增加(从2.8±0.6升至3.3±0.8升/分钟/平方米;p<0.01);然而,每搏量指数未改变(从36±7降至36±8毫升/次/平方米;无显著性差异)。外周血管阻力指数从822±261显著降至610±197达因×秒×厘米-5(p<0.01)。总体而言,基础左心室流出道压差(LVOTG)显著(≥30mmHg)的患者左心室流出道压差未改变(从75±22降至83±22mmHg;无显著性差异),但在6例外周血管阻力下降25%或更多的患者中显著增加(从73±28升至99±22mmHg;p<0.05)。(摘要截选至250字)

相似文献

1
Effects of sublingual nifedipine on hemodynamics and systolic and diastolic function in patients with hypertrophic cardiomyopathy.舌下含服硝苯地平对肥厚型心肌病患者血流动力学及收缩和舒张功能的影响。
Circulation. 1985 Nov;72(5):1001-7. doi: 10.1161/01.cir.72.5.1001.
2
Relation between serum nifedipine concentration and hemodynamic effects in nonobstructive hypertrophic cardiomyopathy.非梗阻性肥厚型心肌病患者血清硝苯地平浓度与血流动力学效应的关系。
Am J Cardiol. 1988 Apr 1;61(10):830-5. doi: 10.1016/0002-9149(88)91075-2.
3
[Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
Schweiz Med Wochenschr. 1982 Sep 18;112(38):1312-7.
4
Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy.硝苯地平对肥厚型心肌病患者左心室舒张异常特性的改善作用
Circulation. 1982 Mar;65(3):499-507. doi: 10.1161/01.cir.65.3.499.
5
Comparison of the effects of nitroprusside and nifedipine on diastolic properties in patients with hypertrophic cardiomyopathy: altered left ventricular loading or improved muscle inactivation?
J Am Coll Cardiol. 1983 Nov;2(5):879-86. doi: 10.1016/s0735-1097(83)80235-6.
6
Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
Chest. 1983 Apr;83(4):704-6. doi: 10.1378/chest.83.4.704.
7
Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure.口服硝苯地平对重度慢性充血性心力衰竭的急性血流动力学效应
Am J Cardiol. 1983 Nov 1;52(8):1041-5. doi: 10.1016/0002-9149(83)90528-3.
8
Effects of nifedipine on left ventricular diastolic function in patients with asymptomatic or minimally symptomatic hypertrophic cardiomyopathy.
Circulation. 1990 Feb;81(2):593-601. doi: 10.1161/01.cir.81.2.593.
9
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.肥厚型心肌病患者的心肌缺血:血管舒张储备不足和左心室充盈压升高的作用。
Circulation. 1985 Feb;71(2):234-43. doi: 10.1161/01.cir.71.2.234.
10
Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy.
Am J Cardiol. 1985 Jan 25;55(3):185B-195B. doi: 10.1016/0002-9149(85)90630-7.

引用本文的文献

1
Hemodynamics in Left-Sided Cardiomyopathies.左心心肌病的血流动力学
Rev Cardiovasc Med. 2024 Dec 24;25(12):455. doi: 10.31083/j.rcm2512455. eCollection 2024 Dec.
2
Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.停用降低后负荷药物可减轻肥厚型梗阻性心肌病患者的左心室流出道梗阻。
Front Cardiovasc Med. 2024 Jul 16;11:1403422. doi: 10.3389/fcvm.2024.1403422. eCollection 2024.
3
Calcium channel antagonists. Part III: Use and comparative efficacy in hypertension and supraventricular arrhythmias. Minor indications.
钙通道拮抗剂。第三部分:在高血压和室上性心律失常中的应用及疗效比较。次要适应症。
Cardiovasc Drugs Ther. 1988 Mar;1(6):625-56. doi: 10.1007/BF02125750.
4
Calcium antagonists--future uses.
Cardiovasc Drugs Ther. 1988 Mar;1(6):613-6. doi: 10.1007/BF02125747.